GlycoEra is a startup based in Switzerland, most recent round Series A, 1 tracked investor.
GlycoEra is a company founded in 2018 headquartered in Switzerland. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
GlycoEra is a Swiss biotech company developing novel biologic drugs using its proprietary GlycoExpress™ platform. This platform enables the precise and efficient production of biologics with tailored glycosylation profiles to enhance therapeutic properties for various diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.